| Teva Pharma AG - Lenvatinib-Teva 4 mg, Hartkapseln | | 70497 | | 01 | | Lenvatinib-Teva 4 mg | | Hartkapseln | | L01EX08 | | Lenvatinib | | 23.03.2026 | | |
| | Composition | | lenvatinibum 4 mg ut lenvatinibi besilas, natrii hydrogenocarbonas corresp. natrium 4.52 mg, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, talcum, Kapselhülle: hypromellosum, E 172 (nigrum), E 172 (flavum), E 172 (rubrum), E 171, Drucktinte: lacca, kalii hydroxidum, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | Principe actif | Concentr. |
|---|
| Lenvatinibum | 4 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Hypromellosum | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Mannitol | | | | Natrii Hydrogenocarbonas | | | | Pro Capsula | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | | | A | | Oui |
|
|
